Trypanosoma cruzi-induced host immune system dysfunction: A rationale for parasite immunosuppressive factor(s) encoding gene targeting

Journal of Biomedicine and Biotechnology

Volumn 2001, Issue 1, 2001, Pages 11-17

  Ouaissi, Ali ^a   Da Silva, Anabela Cordeiro ^b   Guevara, Angel Gustavo ^c   Borges, Margarida ^a   Guilvard, Eliane ^a  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^b UNIVERSITY OF PORTO   (Portugal)

^c HOSPITAL VOZANDES   (Ecuador)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; B LYMPHOCYTE ANTIGEN; COMPLEMENTARY RNA; CYSTEINE; GAMMA INTERFERON; GLUTATHIONE; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN TC24; PROTEIN TC52; PROTOZOAL PROTEIN; TRYPANOSOMA CRUZI VACCINE; UNCLASSIFIED DRUG;

CELL PROLIFERATION; CHAGAS DISEASE; GENE REPLACEMENT THERAPY; GENE TARGETING; HOST PARASITE INTERACTION; HUMAN; IMMUNE DEFICIENCY; IMMUNOREGULATION; INTRACELLULAR SPACE; MACROPHAGE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; REVIEW; T LYMPHOCYTE; TRYPANOSOMA CRUZI;

TRYPANOSOMA CRUZI;

EID: 34249717296     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/S1110724301000055     Document Type: Review

References (21)

1. Takle GB, Snary D. South American trypanosomiasis (Chagas' disease). In: Kenneth S. Warren, ed. Immunology of Parasitic Infections. Blackwell Scientific Publications; 1993:213.
2. Minoprio P, Itohara S, Heusser C, Tonegawa S, Coutinho A. Immunobiology of murine T. cruzi infection: the predominance of parasite-nonspecific responses and the activation of TcRI T cells. Immunol Rev. 1989;112:183.
3. + cells, prevents signs of polyclonal T lymphocyte activation and allows restoration of a resting immune state after challenge. Exp Parasitol. 1999;91:7.
4. Goldenberg S, Cordeiro MN, Silva-Pereira AA, Mares-Guida L. Release of lipopolysaccharide (LPS) from cell surface of Trypanosoma cruzi by EDTA. Int J Parasitol. 1983;13:11.
5. Cordeiro Da Silva A, Espinoza AG, Taibi A, Ouaissi A, Minoprio P. A 24000 MW Trypanosoma cruzi antigen is a B-cell activator. Immunol. 1998;94:189.
6. Guevara AG, Guilvard E, Coutinho Borges M, Cordeiro Da Silva A, Ouaissi A. N-acetylcysteine and glutathione modulates the behaviour of T. cruzi experimental murine infections. Immunol Lett. 2000;71:79.
7. Kierszenbaum F, de Diego JL, Fresno M, Sztein MB. Inhibitory effects of the Trypanosoma cruzi membrane glycoprotein AGC10 on the expression of IL2 receptor chains and secretion of cytokines by subpopulations of activated human T lymphocytes. Eur J Immunol. 1999;29:1684.
8. Schöneck R, Marty B, Taibi A, et al. Trypanosma cruzi cDNA encodes a tandemly repeated domain structure characteristic of small stress proteins and glutathione S-transferases. Biol Cell. 1994;80:1.
9. Ouaissi A, Guevara-Espinoza A, Chabe F, Gomez-Corvera R, Taibi A. A novel and basic mechanism of immunosuppression in Chagas' disease: Trypanosoma cruzi releases in vitro and in vivo a protein which induces T cell unresponsiveness through specific interaction with cysteine and glutathione. Immunol Lett. 1995;48:221.
10. Pestel J, Deffort JP, Gras-Masse H, et al. Polyclonal cell activity of a repeat peptide derived from the sequence of an 85-kilodalton surface protein of Trypanosoma cruzi trypomastigotes. Inf Immun. 1992;60:715.
11. Dröge W, Eck HP, Mihm S. HIV-induced cysteine deficiency andT-cell dysfunction - a rationale for treatment with N-acetylcysteine. Immunol Today. 1992;13:211.
12. Hogg N, Singh RJ, Kalyanaraman B. The role of glutathione in the transport and catabolism of nitric oxide. FEBS Lett. 1996;382:223.
13. Abrahamsohn IA, Coffman RL. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection. J Immunol. 1995;155:3955.
14. Fernandez-Gomez R, Esteban S, Gomez-Corvera R, Zoulika K, Ouaissi A. Trypanosoma cruzi: Tc52 released protein-induced increased expression of nitric oxide synthase and nitric oxide production bymacrophages. J Immunol. 1998;160:3471.
15. James SL. Role of nitric oxide in parasitic infections. Microbiol Rev. 1995;59:533.
16. Rose NR. Myocarditis-from infection to autoimmunity. The Immunologist. 1996;4:67.
17. Allaoui A, François C, Zemzoumi K, Guilvard E, Ouaissi A. Intracellular growth and metacyclogenesis defects in Trypanosoma cruzi carrying a targeted deletion of a Tc52 protein-encoding allele. Mol Microbiol. 999;32:1273.
18. Alves AM, Tanuri A, De Almeida DF, Krüger WMA. Reversible changes in the isoenzyme electrophoretic mobility pattern and infectivity in clones of Trypanosoma cruzi. Exp Parasitol. 1993;77:246.
19. Williams GT. Trypanosoma cruzi: inhibition of intracellular and extracellular differentiation by ADP-ribosyl transferase antagonists. Exp Parasitol. 1983;56:409.
20. Ahn BY, Moss B. Glutaredoxin homolog encoded by vaccinia virus in a virion-associated enzyme with thioltransferase and dehydrogenase reductase activities. Proc Natl Acad Sci USA. 1992;89:7060.
21. Dumas C, Ouellette M, Tovar J, et al. Disruption of the trypanothione reductase gene of Leishmania decreases its ability to survive oxidative stress in macrophages. EMBO J. 1997;16:2590.